AS 602801 (Bentamapimod)
Catalog No. A11296
AS 602801 (Bentamapimod)是一种新型口服活性Jun激酶抑制剂。
- Shuai Zhang, .et al. AS602801 sensitizes glioma cells to temozolomide and vincristine by blocking gap junction communication between glioma cells and astrocytes, J Cell Mol Med, 2021, Apr;25(8):4062-4072 PMID: 33609076
- Kuramoto K, .et al. AS602801, an Anti-Cancer Stem Cell Drug Candidate, Suppresses Gap-junction Communication Between Lung Cancer Stem Cells and Astrocytes, Anticancer Res, 2018, Sep;38(9):5093-5099 PMID: 30194154
Catalog Num | A11296 |
---|---|
M. Wt | 547.6 |
Formula | C25H23N5O2S |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 848344-36-5 |
Synonyms | AS-602801, AS602801 |
SMILES | C1COCCN1CC2=CC=C(C=C2)COC3=NC=CC(=N3)C(C#N)C4=NC5=CC=CC=C5S4 |
AS 602801 (Bentamapimod)是一种新型口服活性Jun激酶抑制剂。
In vitro | DMSO | 21 mg/mL (45.89 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 18.26 mL | 91.31 mL | 182.62 mL |
0.5 mM | 3.65 mL | 18.26 mL | 36.52 mL |
1 mM | 1.83 mL | 9.13 mL | 18.26 mL |
5 mM | 0.37 mL | 1.83 mL | 3.65 mL |
*The above data is based on the productmolecular weight 547.6 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.